Depression and chronic diseases: It is time for a synergistic mental health and primary care approach

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 15, Issue 2, 2013, Pages

  Voinov, Boris ^a   Richie, William D ^a   Bailey, Rahn K ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CELECOXIB; ETANERCEPT; HYDROCORTISONE; INTERLEUKIN 6; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL ABUSE; ANXIETY DISORDER; ARTICLE; BEHAVIOR; BIPOLAR DISORDER; CARDIOVASCULAR DISEASE; CELLULAR IMMUNITY; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; COMORBIDITY; CORONARY ARTERY DISEASE; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; HEALTH CARE POLICY; HEART DISEASE; HUMAN; MAJOR DEPRESSION; MALIGNANT NEOPLASTIC DISEASE; MENTAL HEALTH; MENTAL HEALTH CARE; MOOD DISORDER; MORBIDITY; MORTALITY; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PREVALENCE; PRIMARY MEDICAL CARE; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PSYCHOPHYSIOLOGY; PSYCHOTHERAPY; QUALITY OF LIFE; SCREENING; SLEEP DISORDER; SMOKING; SUBSTANCE ABUSE;

EID: 84877655602     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.12r01468     Document Type: Article

References (71)

1. World Health Organization. The Global Burden of Disease, 2004 Update. Part 4, Burden of Disease, DALYs. http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf. Accessed January 10, 2013.
2. Centers for Disease Control and Prevention (CDC). Current depression among adults: United States, 2006 and 2008. MMWR Morb Mortal Wkly Rep. 2010;59(38):1229-1235. PubMed ShowAbstract ShowAbstract
3. Mykletun A, Bjerkeset O, Overland S, et al. Levels of anxiety and depression as predictors of mortality: the HUNT study. Br J Psychiatry. 2009;195(2):118-125. PubMed doi:10.1192/bjp.bp.108.054866 ShowAbstract ShowAbstract
4. Kessler RC, Soukup J, Davis RB, et al. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry. 2001;158(2):289-294. PubMed doi:10.1176/appi.ajp.158.2.289 ShowAbstract ShowAbstract
5. Blume J, Douglas SD, Evans DL. Immune suppression and immune activation in depression. Brain Behav Immun. 2011;25(2):221-229. PubMed doi:10.1016/j.bbi.2010.10.008 ShowAbstract ShowAbstract
6. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340(2):115-126. PubMed doi:10.1056/NEJM199901143400207 ShowAbstract ShowAbstract
7. Sukhija R, Fahdi I, Garza L, et al. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome. Am J Cardiol. 2007;99(7):879-884. PubMed doi:10.1016/j.amjcard.2006.11.032 ShowAbstract ShowAbstract
8. Tousoulis D, Antoniades C, Koumallos N, et al. Pro-inflammatory cytokines in acute coronary syndromes: from bench to bedside. Cytokine Growth Factor Rev. 2006;17(4):225-233. PubMed doi:10.1016/j.cytogfr.2006.04.003 ShowAbstract ShowAbstract
9. Brown ES, Varghese FP, McEwen BS. Association of depression with medical illness: does cortisol play a role? Biol Psychiatry. 2004;55(1):1-9. PubMed doi:10.1016/S0006-3223(03)00473-6 ShowAbstract ShowAbstract
10. von Känel R. Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence? Acta Psychiatr Scand. 2004;110(3):163-177. PubMed doi:10.1111/j.1600-0447.2004.00308.x ShowAbstract ShowAbstract
11. Wulsin LR, Musselman D, Otte C, et al. Depression and whole blood serotonin in patients with coronary heart disease from the Heart and Soul Study. Psychosom Med. 2009;71(3):260-265. PubMed doi:10.1097/PSY.0b013e31819cc761 ShowAbstract ShowAbstract
12. Watts SW. 5-HT in systemic hypertension: foe, friend or fantasy? Clin Sci (Lond). 2005;108(5):399-412.PubMed doi:10.1042/CS20040364 ShowAbstract ShowAbstract
13. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685-1695.PubMed doi:10.1056/NEJMra043430 ShowAbstract ShowAbstract
14. Vaughan CJ. Prevention of stroke and dementia with statins: effects beyond lipid lowering. Am J Cardiol. 2003;91(456A):23B-29B. PubMed doi:10.1016/S0002-9149(02)03270-8 ShowAbstract ShowAbstract
15. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med. 2006;12(9):1005-1015.PubMed ShowAbstract ShowAbstract
16. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860-867. PubMed doi:10.1038/nature01322 ShowAbstract ShowAbstract
17. Capuron L, Bluthé RM, Dantzer R. Cytokines in clinical psychiatry. Am J Psychiatry. 2001;158(7):1163-1164. PubMed doi:10.1176/appi.ajp.158.7.1163 ShowAbstract ShowAbstract
18. Capuron L, Hauser P, Hinze-Selch D, et al. Treatment of cytokine-induced depression. Brain Behav Immun. 2002;16(5):575-580. PubMed doi:10.1016/S0889-1591(02)00007-7 ShowAbstract ShowAbstract
19. Capuron L, Ravaud A, Dantzer R. Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. JClin Oncol. 2000;18(10):2143-2151. PubMed ShowAbstract ShowAbstract
20. Frasure-Smith N, Lespérance F. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry. 2008;65(1):62-71. PubMed doi:10.1001/archgenpsychiatry.2007.4 ShowAbstract ShowAbstract
21. Sridhar GR. Psychiatric co-morbidity and diabetes. Indian J Med Res. 2007;125(3):311-320. PubMed ShowAbstract ShowAbstract
22. Johansson D, Falk A, Marcus MM, et al. Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Oct 1;39(1):143-148. doi: 10.1016/j.pnpbp.2012.06.003 PubMed
23. Miller AH, Raison CL. Cytokines, p38 MAP kinase and the pathophysiology of depression. Neuropsychopharmacology. 2006;31(10):2089-2090. PubMed doi:10.1038/sj.npp.1301032 ShowAbstract ShowAbstract
24. Miller AH. Inflammation versus glucocorticoids as purveyors of pathology during stress: have we reached the tipping point? Biol Psychiatry. 2008;64(4):263-265. PubMed doi:10.1016/j.biopsych.2008.05.018 ShowAbstract ShowAbstract
25. Rudisch B, Nemeroff CB. Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry. 2003;54(3):227-240. PubMed doi:10.1016/S0006-3223(03)00587-0 ShowAbstract ShowAbstract
26. de Jonge P, van den Brink RH, Spijkerman TA, et al. Only incident depressive episodes after myocardial infarction are associated with new cardiovascular events. JAm Coll Cardiol. 2006;48(11):2204-2208. PubMed doi:10.1016/j.jacc.2006.06.077 ShowAbstract ShowAbstract
27. Bigger JT, Glassman AH. The American Heart Association science advisory on depression and coronary heart disease: an exploration of the issues raised. Cleve Clin J Med. 2010;77(suppl 3):S12-S19. PubMed doi:10.3949/ccjm.77.s3.03 ShowAbstract ShowAbstract
28. Lökk J, Delbari A. Management of depression in elderly stroke patients. Neuropsychiatr Dis Treat. 2010;6:539-549. PubMed doi:10.2147/NDT.S7637 ShowAbstract ShowAbstract
29. Morris PL, Robinson RG, Samuels J. Depression, introversion and mortality following stroke. Aust N Z J Psychiatry. 1993;27(3):443-449. PubMed doi:10.3109/00048679309075801 ShowAbstract ShowAbstract
30. House A, Knapp P, Bamford J, et al. Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month. Stroke. 2001;32(3):696-701. PubMed doi:10.1161/01.STR.32.3.696 ShowAbstract ShowAbstract
31. Pan A, Sun Q, Okereke OI, et al. Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA. 2011;306(11):1241-1249. PubMed doi:10.1001/jama.2011.1282 ShowAbstract ShowAbstract
32. Fan AZ, Strine TW, Huang Y, et al. Self-rated depression and physician-diagnosed depression and anxiety in Florida adults: Behavioral Risk Factor Surveillance System, 2006. Prev Chronic Dis. 2009;6(1):A10. PubMed ShowAbstract ShowAbstract
33. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ. 1989;298(6676):789-794. PubMed doi:10.1136/bmj.298.6676.789 ShowAbstract ShowAbstract
34. Strazzullo P, D'Elia L, Cairella G, et al. Excess body weight and incidence of stroke: meta-analysis of prospective studies with 2 million participants. Stroke. 2010;41(5):e418-e426. PubMed doi:10.1161/STROKEAHA.109.576967 ShowAbstract ShowAbstract
35. Kaptoge S, Di Angelantonio E, Lowe G, et al; Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375(9709):132-140. PubMed doi:10.1016/S0140-6736(09)61717-7 ShowAbstract ShowAbstract
36. Nefs G, Pouwer F, Denollet J, et al. The course of depressive symptoms in primary care patients with type 2 diabetes: results from the Diabetes, Depression, Type D Personality Zuidoost-Brabant (DiaDDZoB) study. Diabetologia. 2012;55(3):608-616. PubMed doi:10.1007/s00125-011-2411-2 ShowAbstract ShowAbstract
37. Katon WJ, Rutter C, Simon G, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care. 2005 Nov;28(11):2668-2672. PubMed
38. Agency for Healthcare Research and Quality. Diabetes Disparities Among Racial and Ethnic Minorities, Fact Sheet. US Department of Health and Human Services Web site. http://www.ahrq.gov/research/diabdisp.htm#HighDiabetes. Accessed February 11, 2013.
39. Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care. 2003;26(10):2822-2828. PubMed doi:10.2337/diacare.26.10.2822 ShowAbstract ShowAbstract
40. Mezuk B, Eaton WW, Albrecht S, et al. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008;31(12):2383-2390. PubMed doi:10.2337/dc08-0985 ShowAbstract ShowAbstract
41. Lloyd CE. Diabetes and mental health; the problem of co-morbidity. Diabet Med. 2010;27(8):853-854. PubMed doi:10.1111/j.1464-5491.2010.03067.x ShowAbstract ShowAbstract
42. Spiegel D. Effects of psychotherapy on cancer survival. Nat Rev Cancer. 2002 May;2(5):383-389. doi:10.1038/nrc800
43. Stommel M, Kurtz ME, Kurtz JC, et al. A longitudinal analysis of the course of depressive symptomatology in geriatric patients with cancer of the breast, colon, lung, or prostate. Health Psychol. 2004;23(6):564-573. PubMed doi:10.1037/0278-6133.23.6.564 ShowAbstract ShowAbstract
44. Hopwood P, Sumo G, Mills J, et al; START Trials Management Group. The course of anxiety and depression over 5 years of follow-up and risk factors in women with early breast cancer: results from the UK Standardisation of Radiotherapy Trials (START). Breast. 2010;19(2):84-91. PubMed doi:10.1016/j.breast.2009.11.007 ShowAbstract ShowAbstract
45. Love RR, Duc NB, Baumann LC, et al. Duration of signs and survival in premenopausal women with breast cancer. Breast Cancer Res Treat. 2004;86(2):117-124. PubMed doi:10.1023/B:BREA.0000032980.55245.c3 ShowAbstract ShowAbstract
46. Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160-174. PubMed doi:10.1016/S1470-2045(11)70002-X ShowAbstract ShowAbstract
47. Mitchell AJ, Meader N, Davies E, et al. Meta-analysis of screening and case finding tools for depression in cancer: evidence based recommendations for clinical practice on behalf of the Depression in Cancer Care consensus group. JAffect Disord. 2012;140(2):149-160. PubMed doi:10.1016/j.jad.2011.12.043 ShowAbstract ShowAbstract
48. Lloyd-Williams M, Shiels C, Taylor F, et al. Depression: an independent predictor of early death in patients with advanced cancer. JAffect Disord. 2009;113(1-2):127-132. PubMed doi:10.1016/j.jad.2008.04.002 ShowAbstract ShowAbstract
49. Onitilo AA, Nietert PJ, Egede LE. Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site. Gen Hosp Psychiatry. 2006;28(5):396-402. PubMed doi:10.1016/j.genhosppsych.2006.05.006 ShowAbstract ShowAbstract
50. Massie MJ. Prevalence of depression in patients with cancer. JNatl Cancer Inst Monogr. 2004;(32):57-71. PubMed doi:10.1093/jncimonographs/lgh014 ShowAbstract ShowAbstract
51. Sand AM, Harris J, Rosland JH. Living with advanced cancer and short life expectancy: patients' experiences with managing medication. JPalliat Care. 2009;25(2):85-91. PubMed ShowAbstract ShowAbstract
52. Sapolsky RM, Donnelly TM. Vulnerability to stress-induced tumor growth increases with age in rats: role of glucocorticoids. Endocrinology. 1985;117(2):662-666. PubMed doi:10.1210/endo-117-2-662 ShowAbstract ShowAbstract
53. Antonova L, Mueller CR. Hydrocortisone down-regulates the tumor suppressor gene BRCA1 in mammary cells: a possible molecular link between stress and breast cancer. Genes Chromosomes Cancer. 2008;47(4):341-352. PubMed doi:10.1002/gcc.20538 ShowAbstract ShowAbstract
54. Barron TI, Connolly RM, Sharp L, et al. Beta blockers and breast cancer mortality: a population- based study. JClin Oncol. 2011;29(19):2635-2644. PubMed doi:10.1200/JCO.2010.33.5422 ShowAbstract ShowAbstract
55. Melhem-Bertrandt A, Chavez-Macgregor M, Lei X, et al. Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. JClin Oncol. 2011;29(19):2645-2652. PubMed doi:10.1200/JCO.2010.33.4441 ShowAbstract ShowAbstract
56. Price A, Hotopf M. The treatment of depression in patients with advanced cancer undergoing palliative care. Curr Opin Support Palliat Care. 2009;3(1):61-66. PubMed doi:10.1097/SPC.0b013e328325d17a ShowAbstract ShowAbstract
57. Rodin G, Katz M, Lloyd N, et al. Treatment of depression in cancer patients. Curr Oncol. 2007;14(5):180-188. PubMed doi:10.3747/co.2007.146 ShowAbstract ShowAbstract
58. Dantzer R, O'Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46-56. PubMed doi:10.1038/nrn2297 ShowAbstract ShowAbstract
59. Mental Health Care Services by Family Physicians Position Paper. American Academy of Family Physicians Web site. http://www.aafp.org/online/en/home/policy/policies/m/mentalhealthcareservices.htm. Accessed February 11, 2013.
60. Position Statement 13: Integration of Mental and General Health Care. Mental Health America Web site. http://www.mentalhealthamerica.net/go/position-statements/13. Accessed February 11, 2013.
61. Rosenthal MH. The challenge of comorbid disorders in patients with depression. JAm Osteopath Assoc. 2003;103(suppl 4):S10-S15. PubMed ShowAbstract ShowAbstract
62. Patient Health Questionnaire PHQ-9 for Depression. http://www.depression-primarycare.org/images/pdf/phq_9_eng.pdf. Accessed January 10, 2013.
63. Sowden G, Mastromauro CA, Januzzi JL, et al. Detection of depression in cardiac inpatients: feasibility and results of systematic screening. Am Heart J. 2010;159(5):780-787. PubMed doi:10.1016/j.ahj.2010.02.029 ShowAbstract ShowAbstract
64. Faulstich ME, Carey MP, Ruggiero L, et al. Assessment of depression in childhood and adolescence: an evaluation of the Center for Epidemiological Studies Depression Scale for Children (CES-DC). Am J Psychiatry. 1986;143(8):1024-1027.
65. Pediatric Symptom Checklist. http://www.massgeneral.org/psychiatry/services/psc_home.aspx. Accessed January 10, 2013.
66. Spence Children's Anxiety Scale. http://www.scaswebsite.com/. Accessed January 10, 2013.
67. Dennis ML, Feeney T, Stevens LH, et al. GAIN-SS. Global Appraisal of Individual Needs-Short Screener: Administration and Scoring Manual. http://www.assessments.com/assessments_documentation/gain_ss/GAIN-SS%20Manual.pdf. Accessed January 10, 2013.
68. Office of the Surgeon General. Report of a Surgeon General's Working Meeting on The Integration of Mental Health Services and Primary Health Care. Held on November 30-December 1, 2000, at the Carter Center, Atlanta, Georgia. Rockville, Maryland: Office of the Surgeon General; 2001. http://www.ncbi.nlm.nih.gov/books/NBK44335/. Accessed February 26, 2013.
69. US Department of Health and Human Services Web site. http://www.healthypeople.gov/2020/default.aspx.
70. About SAMHSA's Wellness Efforts. Why Wellness Matters. http://promoteacceptance.samhsa.gov/10by10//. Substance Abuse and Mental Health Services Web site.
71. SAMHSA. Health homes and primary and behavioral health care integration. http://www.samhsa.gov/Healthreform/healthHomes/index.aspx. Updated July 16, 2012. Accessed January 10, 2013.